Jul 22, 2019

Paul Kohlhaas, Founder, Molecule is passionate about creating a network for the decentralization of the process of researching new molecules and developing new molecular compounds using blockchain to track and reward all those who participate.  With the current pharma innovation crisis and rising costs of drug...

Jul 22, 2019

Paul Kohlhaas, Founder, Molecule is passionate about creating a network for the decentralization of the process of researching new molecules and developing new molecular compounds using blockchain to track and reward all those who participate.  With the current pharma innovation crisis and rising costs of drug...

Apr 8, 2019

Dr. Hartmut Ehrlich, CEO of Abivax discusses the exciting new progress that this French biotechnology company has observed in clinical trials of their most advanced clinical drug candidate, ABX464.  Originally designed to treat HIV by reducing the viral reservoir, Abivax determined the molecule could also be...

Jul 19, 2018

Pierre Laurin, B.Sc.Pharm., M.Sc is President and CEO, Prometic Life Sciences, a company working to address varying forms of fibrosis. Pierre points out how much researchers have learned about fibrosis just over the last 10 years and how it is more common than you may think attacking vital organs for a variety of...

Feb 28, 2018

Nawal Ouzren, CEO, Sensorion talks about recent studies that have shown the dramatic impact of hearing loss on the elderly as well as children putting all at risk for social isolation. For kids hearing loss can hinder their social development, and for seniors it can increase their risk for dementia.  Nawal talks about...